Share this page!

Enter URL or ID to Unroll

You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649

How to get URL link on X (Twitter) App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
Brad Loncar Profile picture
Brad Loncar
@bradloncar
#Biotech enthusiast, Founder of @BiotechTVHQ, KC native, @univmiami hurricane.🧬🙌
Dec 29, 2022 • 11 tweets • 4 min read
🧵 Here are 10 amazing things that happened this year in #biotech.🧬 1. A HER2 targeting antibody-drug conjugate's stellar data redefined how breast cancer is categorized and offers a new treatment option for a large percentage of those with breast cancer in the future. fiercepharma.com/pharma/asco-as…
Apr 13, 2022 • 19 tweets • 2 min read
Biotech has been depressing lately, but some positive things have recently shown signs of life:

1. ARGX APLS raising $$ on data.
2. Hated IGMS gets a nice deal.
3. SRRA and ATRS M&A. 4. REGN is a buyer and scoops up neglected CMPI
Aug 5, 2019 • 5 tweets • 2 min read
I give J.P. Morgan credit for being the only firm on the street cautious on Mirati. When was the last time so much value was given to a drug w/ no data? Piper analyst just now says the stock could go to $200 w/ great data at the triple. Well, what happens if it’s not so great? With the exception of JPM, the entire sell side is taking a FOMO approach to talking about this thing.